Grants help propel glaucoma, macular degeneration research
Three Vanderbilt University Medical Center faculty members have been awarded grants from the American Health Assistance Foundation to support their research on glaucoma and macular degeneration — the two leading causes of irreversible blindness in the world.
Vanderbilt Eye Institute researchers received three of the 21 grants given by the organization tasked with funding breakthrough research on age-related vision diseases.
• John Kuchtey, Ph.D., research assistant professor of Ophthalmology and Visual Sciences at VEI, and colleagues are studying ways to detect the genes causing inherited glaucoma in newborns and infants.
• Milam Brantley Jr., M.D., Ph.D., assistant professor of Ophthalmology and Visual Sciences and director of the Initiative for Ocular Pharmacogenomics at VEI, is studying the environmental risks for age-related macular degeneration (AMD).
• Ashwath Jayagopal, Ph.D., assistant professor of Ophthalmology and Visual Sciences at VEI, and colleagues are working on developing nanotechnology-based approaches for imaging critical biomarkers of early wet AMD.